FNY Managed Accounts LLC - DIPEXIUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
FNY Managed Accounts LLC ownership history of DIPEXIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$2,175,000
-68.9%
150
-70.0%
0.00%
-90.0%
Q3 2015$7,000,000
-21.4%
500
-28.6%
0.02%
+81.8%
Q2 2015$8,904,0007000.01%
Other shareholders
DIPEXIUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 22,555$36,0000.02%
MIDDLETON & CO INC/MA 15,848$25,0000.01%
Tower Research Capital LLC (TRC) 13,480$21,0000.00%
FIRST NEW YORK SECURITIES LLC /NY 500$800,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 43,219$69,0000.00%
Raymond James Financial Services Advisors, Inc. 10,200$16,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
BlackRock Investment Management, LLC 956$2,0000.00%
GOLDMAN SACHS GROUP INC 24,377$39,0000.00%
MORGAN STANLEY 8,054$12,0000.00%
View complete list of DIPEXIUM PHARMACEUTICALS INC shareholders